The Global RSV Vaccine And mAb Landscape

The presentation was delivered and recorded during the 7th Lifecourse Summit 2022

Presentation from the 7th Lifecourse Summit providing a comprehensive overview of the global RSV prevention pipeline, detailing vaccine candidates and monoclonal antibody developments across different target populations. This session further explores the subject in depth, highlighting key takeaways, implications for policy and practice, and insights from the expert presenter to help inform future strategies.